Ciprofloxacin
Ciprofloxacin is a broad-spectrum antibiotic used in the laboratory setting. It is a fluoroquinolone compound that inhibits bacterial DNA gyrase and topoisomerase IV, essential enzymes for bacterial replication and transcription.
Lab products found in correlation
12 protocols using ciprofloxacin
Fluoroquinolone Susceptibility in Enterococcus
Antibiotic Susceptibility Testing of E. coli
Antibacterial Agents: Comprehensive Evaluation
Reagents and Materials Procurement for Biomolecular Research
Graphene Oxide-based Fluoroquinolone Detection
Screening Antibiotic Resistance Genes and Potential Inhibitors
The full gene sequences of blaIMP-1, blaVIM-1, blaKPC-2 and blaOXA-48 were synthesized by GeneScript (Nanjing, China) and were inserted into pET28a or pETSUMO for protein expression.
The FDA-approved drug library was purchased from ApexBio Technology (Cat#L1021, Houston, TX, USA). Dexrazoxane, embelin, CAN and NDGA were dissolved in DMSO (Sigma-Aldrich, St. Louis, MO, USA). Meropenem, amoxicillin, ciprofloxacin, imipenem, erythromycin, chloramphenicol, tetracycline and gentamicin were obtained from Dalian Meilun Biotechnology Co., Ltd. (Dalian, China).
Antibacterial Agents Procurement and Media Preparation
Quantitative Analysis of Antibiotics
Antimicrobial Susceptibility Testing of Mycoplasma spp.
The minimum bactericidal concentrations (MBCs) for nemonoxacin was determined as previously described (Waites et al., 2017a (link)), which included 11 M. pneumoniae isolates, 5 M. hominis isolates, and 5 Ureaplasma spp. isolates. The positive and negative controls consisted of tetracycline (bacteriostatic) and moxifloxacin (bactericidal), respectively. When the MBC was ≥3 dilutions (eightfold) greater than the MIC, the drug was considered bacteriostatic. MBCs that were ≤2 dilutions (fourfold) greater than the MIC were considered bactericidal.
Synthesis and Characterization of ZG Compounds and Antibiotic Purchases
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!